Strategies for the development of drugs for pharmacoresistant epilepsies.
about
Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug DevelopmentA new potential AED, carisbamate, substantially reduces spontaneous motor seizures in rats with kainate-induced epilepsySeizure-induced reduction in PIP3 levels contributes to seizure-activity and is rescued by valproic acid.Animal models of limbic epilepsies: what can they tell us?The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium.Anticonvulsant activities of the FS-1 subfraction isolated from roots of Delphinium denudatum.The Ethanol Fraction of White Rose Petal Extract Abrogates Excitotoxicity-Induced Neuronal Damage and through Inhibition of Oxidative Stress and Proinflammation
P2860
Q33677979-78D51735-F556-45C5-AC31-ADFA49726D16Q34052278-C1C338BC-6E16-4AF8-AAC3-640BCCDB6C1CQ34379505-E45714F6-C4E0-4674-8CC6-53800A02B73AQ34604307-0CDC8E13-FFFB-4FB9-BC38-E8C63C25DFDBQ35665058-46049FC4-5125-492A-912A-E188D448B187Q43708820-830DCAE3-6C87-4516-9082-A76B236DB2FCQ58692095-0CF6C6B6-AAFB-4E8D-8CD7-1B1D1534DDDA
P2860
Strategies for the development of drugs for pharmacoresistant epilepsies.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Strategies for the development of drugs for pharmacoresistant epilepsies.
@en
type
label
Strategies for the development of drugs for pharmacoresistant epilepsies.
@en
prefLabel
Strategies for the development of drugs for pharmacoresistant epilepsies.
@en
P2093
P2860
P1433
P1476
Strategies for the development of drugs for pharmacoresistant epilepsies.
@en
P2093
P2860
P304
P356
10.1111/J.1528-1157.1994.TB05959.X
P478
35 Suppl 5
P577
1994-01-01T00:00:00Z